Peripheral Vascular Devices Market, By Product Type (Peripheral Vascular Stents, Peripheral Transluminal Angioplasty Balloon Catheters, PTA Guidewires, Atherectomy Devices, Chronic Total Occlusion Devices, Aortic Stents, Synthetic Surgical Grafts, Others)

Peripheral Vascular Devices Market, By Product Type (Peripheral Vascular Stents, Peripheral Transluminal Angioplasty Balloon Catheters, PTA Guidewires, Atherectomy Devices, Chronic Total Occlusion Devices, Aortic Stents, Synthetic Surgical Grafts, Others), By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Global peripheral vascular devices market has been witnessing steady growth over the past few years owing to increasing geriatric population and prevalence of lifestyle diseases. Peripheral vascular devices are majorly used in diagnosis and treatment of peripheral artery disease (PAD), a condition characterized by narrowed arteries reducing blood flow to limbs. Rising research activities focusing on development of advanced technologies such as drug-eluting stents and scoring balloon catheters is expected to positively influence the market expansion during the forecast period. Favorable reimbursement scenario in developed economies and growing awareness regarding early diagnosis are supplementing the market growth. However, high cost of treatment accompanied with certain procedures and strict regulatory approvals are some of the major factors impeding the market growth.

Market Dynamics:

Global peripheral vascular devices market growth is primarily driven by increasing geriatric population prone to chronic diseases, growing prevalence of lifestyle diseases such as diabetes, obesity leading to peripheral artery disease as well as rising research initiatives for development of innovative devices. High risk of contracting PAD in diabetic patients boosts the need for effective diagnostic and interventional procedures, thereby, fueling demand for peripheral vascular devices. However, high cost of technologically advanced devices and treatment procedures along with stringent regulatory policies for new product approvals are major challenges restraining the market growth. Meanwhile, ongoing research & development activities embarked by key players to introduce bio-absorbable stents and efficient drug delivery systems present lucrative opportunities for market players over the forecast period.

Key Features of the Study:

• This report provides in-depth analysis of the global peripheral vascular devices market, and provides market size (USD BN) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global peripheral vascular devices market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study includes Abbott Laboratories, Boston Scientific Corporation, Angioscore, Emboline Inc., Becton Dickinson and Company, Cook Group Inc., Cordis Corporation, Covidien PLC, Edward Lifesciences Corporation, Medtronic Plc, St. Jude Medical, Bayer AG, Teleflex Medical, Koninklijke Philips N.V., and Cardio Flow, Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• Global peripheral vascular devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global peripheral vascular devices market.

Detailed Segmentation-

• Product Type:
• Peripheral Vascular Stents
• Peripheral Transluminal Angioplasty Balloon Catheters
• PTA Guidewires
• Atherectomy Devices
• Chronic Total Occlusion Devices
• Aortic Stents
• Synthetic Surgical Grafts
• Others
• End User:
• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Others
• Region:
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East
• Africa
• Company Profiles:
• Abbott Laboratories
• Boston Scientific Corporation
• Angioscore
• Emboline Inc.
• Becton Dickinson and Company
• Cook Group Inc.
• Cordis Corporation
• Covidien PLC
• Edward Lifesciences Corporation
• Medtronic Plc
• Jude Medical
• Bayer AG.
• Teleflex Medical
• Koninklijke Philips N.V.
• Cardio Flow, Inc.